0001209191-19-026320.txt : 20190426 0001209191-19-026320.hdr.sgml : 20190426 20190426200650 ACCESSION NUMBER: 0001209191-19-026320 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190425 FILED AS OF DATE: 20190426 DATE AS OF CHANGE: 20190426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAVIOLETTE PAUL A CENTRAL INDEX KEY: 0001191249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 19773390 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-25 0 0000876378 TRANSENTERIX INC. TRXC 0001191249 LAVIOLETTE PAUL A ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 1 0 0 0 Common Stock 2019-04-25 4 A 0 20606 0.00 A 20606 D Common Stock 2019-04-25 4 A 0 20380 0.00 A 40986 D Stock Option Award 1.96 2019-04-25 4 A 0 29104 0.00 A 2029-04-25 Common Stock 29104 29104 D Stock Option Award 1.96 2019-04-25 4 A 0 29428 0.00 A 2029-04-25 Common Stock 29428 29428 D Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period. Amount of securities beneficially owned following reported transactions reflects the required assignment by the reporting person to an affiliated fund of the right to receive 40,950 shares of common stock upon vesting, on April 24, 2019, of RSUs granted to the reporting person on May 24, 2018. The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant. The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. No acceleration of vesting for any unvested stock options upon the consummation of a change in control of the registrant. /s/ Joshua Weingard attorney-in-fact for Paul A. LaViolette 2019-04-26